Immunotherapy in mastitis: state of knowledge, research gaps and way forward DOI Creative Commons
Afnan Saleem, Sahar Saleem,

Faith Omonijo

et al.

Veterinary Quarterly, Journal Year: 2024, Volume and Issue: 44(1), P. 1 - 23

Published: July 7, 2024

Mastitis is an inflammatory condition that affects dairy cow's mammary glands. Traditional treatment approaches with antibiotics are increasingly leading to challenging scenarios such as antimicrobial resistance. In order mitigate the unwanted side effects of antibiotics, alternative strategies those harness host immune system response, also known immunotherapy, have been implemented. Immunotherapy treat bovine mastitis aims enhance response against pathogens by promoting pathogen clearance, and facilitating tissue repair. Various studies demonstrated potential immunotherapy for reducing incidence, duration severity mastitis. Nevertheless, majority reported therapies lacking in specificity hampering their broad application Meanwhile, advancements hold great promise industry, provide effective sustainable alternatives traditional antibiotic-based approaches. This review synthesizes strategies, current understanding future perspectives. The perspectives should focus on development precision immunotherapies tailored address individual pathogens/group pathogens, combination resistance, integration nano- omics technologies. By addressing research gaps, field can make significant strides control, prevention mastitis, ultimately benefiting both animal human health/welfare, environment health.

Language: Английский

Epitranscriptomic modifications in mesenchymal stem cell differentiation: advances, mechanistic insights, and beyond DOI
Jiarong Zheng, Ye Lu, Yunfan Lin

et al.

Cell Death and Differentiation, Journal Year: 2023, Volume and Issue: 31(1), P. 9 - 27

Published: Nov. 20, 2023

Language: Английский

Citations

16

TRMT10A dysfunction perturbs codon translation of initiator methionine and glutamine and impairs brain functions in mice DOI Creative Commons

Roland Tresky,

Yuta Miyamoto, Yu Nagayoshi

et al.

Nucleic Acids Research, Journal Year: 2024, Volume and Issue: 52(15), P. 9230 - 9246

Published: July 2, 2024

Abstract In higher eukaryotes, tRNA methyltransferase 10A (TRMT10A) is responsible for N1-methylguanosine modification at position nine of various cytoplasmic tRNAs. Pathogenic mutations in TRMT10A cause intellectual disability, microcephaly, diabetes, and short stature humans, generate cytotoxic fragments cultured cells; however, it not clear how supports codon translation or brain functions. Here, we generated Trmt10a null mice showed that tRNAGln(CUG) initiator methionine levels were universally decreased tissues; the same was true a human cell line lacking TRMT10A. Ribosome profiling mouse revealed dysfunction causes ribosome slowdown Gln(CAG) increases Atf4 due to frequency leaky scanning its upstream open reading frames. Broadly speaking, subset mRNAs, especially those neuronal structures, perturbed mutant brain. Despite showing discernable defects pancreas, liver, kidney, lower body weight smaller hippocampal postsynaptic densities, which associated with defective synaptic plasticity memory. Taken together, our study provides mechanistic insight into roles brain, exemplifies importance universal during specific codons.

Language: Английский

Citations

7

NAT10 promotes vascular remodelling via mRNA ac4C acetylation DOI
Yu Cheng, Yue Chen,

Hao Luo

et al.

European Heart Journal, Journal Year: 2024, Volume and Issue: unknown

Published: Oct. 25, 2024

Vascular smooth muscle cell (VSMC) phenotype switching is a pathological hallmark in various cardiovascular diseases. N4-acetylcytidine (ac4C) catalyzed by N-acetyltransferase 10 (NAT10) well conserved the enzymatic modification of ribonucleic acid (RNA). NAT10-mediated ac4C acetylation involved physiological and processes, including cardiac remodelling. However, biological functions underlying regulatory mechanisms mRNA modifications vascular diseases remain elusive.

Language: Английский

Citations

7

Single-cell and spatial transcriptomics: Bridging current technologies with long-read sequencing DOI
Chengwei Ulrika Yuan, Fu Xiang Quah, Martin Hemberg

et al.

Molecular Aspects of Medicine, Journal Year: 2024, Volume and Issue: 96, P. 101255 - 101255

Published: Feb. 17, 2024

Language: Английский

Citations

6

Immunotherapy in mastitis: state of knowledge, research gaps and way forward DOI Creative Commons
Afnan Saleem, Sahar Saleem,

Faith Omonijo

et al.

Veterinary Quarterly, Journal Year: 2024, Volume and Issue: 44(1), P. 1 - 23

Published: July 7, 2024

Mastitis is an inflammatory condition that affects dairy cow's mammary glands. Traditional treatment approaches with antibiotics are increasingly leading to challenging scenarios such as antimicrobial resistance. In order mitigate the unwanted side effects of antibiotics, alternative strategies those harness host immune system response, also known immunotherapy, have been implemented. Immunotherapy treat bovine mastitis aims enhance response against pathogens by promoting pathogen clearance, and facilitating tissue repair. Various studies demonstrated potential immunotherapy for reducing incidence, duration severity mastitis. Nevertheless, majority reported therapies lacking in specificity hampering their broad application Meanwhile, advancements hold great promise industry, provide effective sustainable alternatives traditional antibiotic-based approaches. This review synthesizes strategies, current understanding future perspectives. The perspectives should focus on development precision immunotherapies tailored address individual pathogens/group pathogens, combination resistance, integration nano- omics technologies. By addressing research gaps, field can make significant strides control, prevention mastitis, ultimately benefiting both animal human health/welfare, environment health.

Language: Английский

Citations

6